Johnson & Johnson spent a whopping $7.55 billion, coming in second behind eye care-developer Alcon, which spent more than $9.5 billion. Meanwhile, Medtronic spent a reported $1.5 billion.
The average amount spent on research and development projects last year was $540 million.
More Articles on Orthopedic Devices:
Conmed’s Arthroscopic Business Line Sees 15% Growth
CareFusion Reports $968M 4Q Revenue, Up 3%
8 Spine Device Company 2Q Financial Reports
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
